Dexamethasone palmitate

CAS No. 14899-36-6

Dexamethasone palmitate( DXP )

Catalog No. M26663 CAS No. 14899-36-6

Dexamethasone palmitate, a lipophilic prodrug of Dexamethasone, shows a 47-fold lower affinity for the glucocorticoid receptor than Dexamethasone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 Get Quote
10MG 63 Get Quote
25MG 101 Get Quote
50MG 138 Get Quote
100MG 237 Get Quote
200MG 353 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dexamethasone palmitate
  • Note
    Research use only, not for human use.
  • Brief Description
    Dexamethasone palmitate, a lipophilic prodrug of Dexamethasone, shows a 47-fold lower affinity for the glucocorticoid receptor than Dexamethasone.
  • Description
    Dexamethasone palmitate, a lipophilic prodrug of Dexamethasone, shows a 47-fold lower affinity for the glucocorticoid receptor than Dexamethasone. Dexamethasone palmitate is a glucocorticoid receptor agonist and an anti-inflammatory agent.(In Vivo):In a murine collagen-induced arthritis model, their passive accumulation in arthritic joints leads to disease remission and recovery of the joint structure at a dose of 1 mg/kg dexamethasone, without any adverse effects.
  • In Vitro
    Dexamethasone palmitate (100 μg/mL; 48 h) affects cytokines concentration of RAW 264.7 cells.Cell Viability Assay Cell Line:RAW 264.7 cells Concentration:100 μg/mL Incubation Time:48 hours Result:Showed vitro anti-inflammatory effects and decreased LPS-induced MCP-1 and TNF-α concentration in RAW 264.7 cells.
  • In Vivo
    Dexamethasone palmitate (1280 μg; IVT injection once) shows different distribution in ocular tissue at different times.Dexamethasone palmitate (280-1280 μg; IVT injection once) affects VEGF-induced vascular hyperpermeability. Animal Model:New Zealand White rabbitsDosage:1280 μgAdministration:IVT injection; 1280 μg onceResult:Mostly distributed in vitreous and still existed till 9 months. The least distributed in aqueous humor and almost disappeared till 6 months.Animal Model:New Zealand White rabbits with VEGF injectionDosage:280, 560 and 1280 μg Administration:IVT injection; 280-1280 μg once Result:After 9 months administration VEGF-induced vascular permeability was controlled at a concentration of 1280 μg, besides 280 and 560 μg also reduced VEGF-induced vascular hyperpermeability after administration for 4 months.
  • Synonyms
    DXP
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14899-36-6
  • Formula Weight
    630.882
  • Molecular Formula
    C38H59FO6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (79.26 mM)
  • SMILES
    [H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)CCCCCCCCCCCCCCC)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
  • Conduritol B epoxide

    Conduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).

  • Oxfendazole

    Oxfendazole is a broad spectrum benzimidazole anthelmintic.

  • Diosbulbin B

    Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.